AMIRA PHARMACEUTICALS, INC. ACQUISITION (Tables)

9 Months Ended

Sep. 30, 2011

Business Combinations [Abstract]

Schedule of Purchase Price Allocation [Table Text Block]

Purchase price:		Dollars in Millions
Cash	$	325
Fair value of contingent consideration		58
Total purchase price		383
Identifiable net assets:
Cash		15
In-process research and development		160
Accrued expenses		(16)
Deferred tax liabilities		(43)
Total identifiable net assets		116
Goodwill	$	267